{"data":{"id":"us/21-cfr-530.23","jurisdiction":"us","citation":"21 CFR 530.23","heading":"Procedure for setting and announcing safe levels.","body":"(a) FDA may issue an order establishing a safe level for a residue of an extralabel use of an approved human drug or an approved animal drug. The agency will publish in the Federal Register a notice of the order. The notice will include:\n(1) A statement setting forth the agency's finding that there is a reasonable probability that extralabel use in animals of the human drug or animal drug may present a risk to the public health;\n(2) A statement of the basis for that finding; and\n(3) A request for public comments.\n(b) A current listing of those drugs for which a safe level for extralabel drug use in food-producing animals has been established, the specific safe levels, and the availability, if any, of a specific analytical method or methods for drug residue detection will be codified in § 530.40.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 530—EXTRALABEL DRUG USE IN ANIMALS","Subpart C—Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"d7b1d63e46d2653bd9a6befa6ea4b0b0870bfdda4397f18c729900203834b0e5","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-530.22","next":"us/21-cfr-530.24"},"notice":"GroundRules: Original legal text. Not legal advice."}